Ken Griffin Bionano Genomics, Inc. Transaction History

Citadel Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.06 - $1.97 $1.51 Million - $2.8 Million	-1,420,266 Reduced 72.46%	539,679 $599,000
Q4 2022 Feb 14, 2023	BUY	$1.4 - $25.4 $1.06 Million - $19.2 Million	755,326 Added 62.7%	1,959,945 $2.86 Million
Q3 2022 Nov 14, 2022	SELL	$0.36 - $36.0 $289,480 - $28.9 Million	-804,112 Reduced 40.03%	1,204,619 $2.21 Million
Q2 2022 Aug 15, 2022	BUY	$12.3 - $27.3 $15.2 Million - $33.8 Million	1,236,369 Added 160.08%	2,008,731 $2.77 Million
Q1 2022 May 16, 2022	SELL	$16.6 - $32.3 $44.8 Million - $87.3 Million	-2,701,802 Reduced 77.77%	772,362 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $96.1 Million - $197 Million	3,212,805 Added 1229.27%	3,474,164 $0
Q3 2021 Nov 15, 2021	BUY	$51.4 - $68.2 $5.54 Million - $7.36 Million	107,846 Added 70.25%	261,359 $1.44 Million
Q2 2021 Aug 16, 2021	SELL	$44.1 - $84.0 $104 Million - $199 Million	-2,365,277 Reduced 93.91%	153,513 $0
Q1 2021 May 17, 2021	BUY	$47.0 - $155.7 $118 Million - $392 Million	2,518,790 New	2,518,790 $20.4 Million
Q4 2020 Feb 16, 2021	SELL	$4.8 - $30.8 $204,374 - $1.31 Million	-42,578 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.7 - $8.9 $834,621 - $1.58 Million	-177,579 Reduced 80.66%	42,578 $28,000
Q2 2020 Aug 14, 2020	BUY	$2.6 - $5.7 $572,408 - $1.25 Million	220,157 New	220,157 $112,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.